The Department of Justice accused Yale University’s medical school of unlawfully using race in admissions, alleging that Black and Hispanic applicants had a higher chance of admission than White and Asian applicants with similar academic profiles. The DOJ’s civil-rights statement says Yale continued a race-based admissions program despite the Supreme Court’s mandate for reform. In related reporting, the DOJ’s approach fits a broader enforcement pattern targeting medical schools and alleged reliance on racial proxies. Yale said it would review the DOJ letter and defended its admissions process as rigorous, emphasizing academic achievement and personal commitment. The allegations matter immediately for medical education admissions operations, especially because DOJ scrutiny can drive institutional compliance audits, changes to admissions review procedures, and increased documentation requirements for selection criteria. Higher education leaders will also monitor the legal and administrative consequences—whether the DOJ seeks remedial action and how the university’s policies evolve under potential investigation timelines.